How Long Do Most Seizures Last? A Systematic Comparison of Seizures Recorded in the Epilepsy Monitoring Unit
Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EE...
Saved in:
Published in | Epilepsia (Copenhagen) Vol. 47; no. 9; pp. 1499 - 1503 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Malden, USA
Blackwell Publishing Inc
01.09.2006
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 0013-9580 1528-1167 |
DOI | 10.1111/j.1528-1167.2006.00622.x |
Cover
Abstract | Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration.
Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic–clonic (SGTCS), primary generalized tonic–clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic–clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed.
Results: Five hundred seventy‐nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin.
Conclusion: A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children. |
---|---|
AbstractList | Purpose:
More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration.
Methods:
Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic–clonic (SGTCS), primary generalized tonic–clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic–clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed.
Results:
Five hundred seventy‐nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin.
Conclusion:
A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children. Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic–clonic (SGTCS), primary generalized tonic–clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic–clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Results: Five hundred seventy‐nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. Conclusion: A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children. Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Methods: Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS-CP) and a tonic-clonic part (SGTCS-TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Results: Five hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. Conclusion: A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children. More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration. Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic-clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed. Five hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin. A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children. More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration.PURPOSEMore information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could influence seizure duration.Data were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic-clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed.METHODSData were collected from a random sample of patients being evaluated with continuous video and scalp EEG. Seizure duration was defined as time from early sign of seizure (clinical or EEG) until the end of seizure on EEG. Seizures were categorized as simple partial (SPS), complex partial (CPS), secondarily generalized tonic-clonic (SGTCS), primary generalized tonic-clonic (PGTCS) and tonic (TS). SGTCS were divided into a complex partial part (SGTCS/CP) and a tonic-clonic part (SGTCS/TC). Median and longest duration of each seizure type in each individual were used. Comparisons of seizure types, first and last seizure, area of onset, and state of onset were performed.Five hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin.RESULTSFive hundred seventy-nine seizures were recorded in 159 adult patients. Seizures with partial onset spreading to both hemispheres had the longest duration. SGTCS were unlikely to last more than 660 s, CPS more than 600 s, and SPS more than 240 s. PGTCS and TS had shorter durations, but the number of subjects with those two types was small. CPS did not differ in duration according to sleep state at onset nor side of origin.A working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children.CONCLUSIONA working definition of status epilepticus in adults with cryptogenic or symptomatic epilepsy can be drawn from these data for purposes of future epidemiologic research. More information is needed for the idiopathic epilepsies and in children. |
Author | Sperling, Michael R. Jenssen, Sigmund Gracely, Edward J. |
Author_xml | – sequence: 1 givenname: Sigmund surname: Jenssen fullname: Jenssen, Sigmund – sequence: 2 givenname: Edward J. surname: Gracely fullname: Gracely, Edward J. – sequence: 3 givenname: Michael R. surname: Sperling fullname: Sperling, Michael R. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18185695$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16981866$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV1rFDEUhoNU7Hb1L0hu9G7GfEwyCYhS1tUWVhRbr0M2k9EsM8k0ydKuv96su7bgTQ2EHDjPeQLnPQMnPngLAMSoxuW82dSYEVFhzNuaIMTrcgmp756A2X3jBMwQwrSSTKBTcJbSBiHU8pY-A6eYS4EF5zMwXIRbuAr-B_wQ4OeQMryy7tc22gRXOuX38Bxe7VK2o87OwEUYJx1dCh6G_oH8Zk2Ine2g8zD_tHA5ucFOaVeE3uUQXdF_L9Vz8LTXQ7Ivju8cXH9cXi8uqtWXT5eL81VlGklJpQlHa6rXgnEskGnbzuJ1b3vWlbZgjJCmaQjTXHLaMoJx1xjTSs4twlhqOgevD9ophputTVmNLhk7DNrbsE2KC8GplPhREEtGKeWkgC-P4HY92k5N0Y067tTfPRbg1RHQyeihj9oblx64QjFebHPw7sCZGFKKtlfG5bLa4HPUblAYqX3AaqP2Oap9jmofsPoTsLorAvGP4P6Px0ffHkZvSzq7_55Ty6-XpaC_AeJhupw |
CODEN | EPILAK |
CitedBy_id | crossref_primary_10_32708_uutfd_1441708 crossref_primary_10_1242_dmm_036194 crossref_primary_10_1212_WNL_0000000000200354 crossref_primary_10_1097_CCM_0b013e31828a3994 crossref_primary_10_1111_j_1528_1167_2007_01420_x crossref_primary_10_1016_j_ncl_2021_08_001 crossref_primary_10_1016_j_nbd_2022_105637 crossref_primary_10_1016_j_pediatrneurol_2018_05_012 crossref_primary_10_1186_s43163_021_00114_9 crossref_primary_10_1017_S0317167100054093 crossref_primary_10_4065_84_6_495 crossref_primary_10_1111_epi_17089 crossref_primary_10_1111_j_1535_7511_2010_01368_x crossref_primary_10_1016_j_cpem_2015_01_001 crossref_primary_10_3390_biomedicines10071491 crossref_primary_10_1016_j_seizure_2014_05_009 crossref_primary_10_1055_a_2180_7621 crossref_primary_10_1111_ane_12814 crossref_primary_10_1109_ACCESS_2019_2915609 crossref_primary_10_1097_ACO_0000000000000376 crossref_primary_10_1016_j_neuroscience_2007_05_047 crossref_primary_10_3389_fneur_2021_724904 crossref_primary_10_1111_epi_13291 crossref_primary_10_1016_j_clineuro_2014_02_023 crossref_primary_10_1055_a_2114_7954 crossref_primary_10_1111_epi_17756 crossref_primary_10_1002_acn3_50941 crossref_primary_10_1097_PEC_0000000000002745 crossref_primary_10_1111_j_1528_1167_2008_01669_x crossref_primary_10_1016_j_yebeh_2020_107145 crossref_primary_10_1055_a_2029_4196 crossref_primary_10_1111_epi_14521 crossref_primary_10_14581_jer_11011 crossref_primary_10_1109_ACCESS_2018_2853125 crossref_primary_10_1056_NEJMcpc2027080 crossref_primary_10_1016_j_ncl_2023_04_001 crossref_primary_10_1016_j_nrl_2016_12_003 crossref_primary_10_1002_epd2_20243 crossref_primary_10_1016_j_seizure_2015_03_002 crossref_primary_10_1109_JIOT_2024_3395496 crossref_primary_10_5863_1551_6776_20_4_260 crossref_primary_10_1007_s12098_019_02946_z crossref_primary_10_1002_epi4_12457 crossref_primary_10_1109_JBHI_2022_3208780 crossref_primary_10_1016_j_yebeh_2016_09_020 crossref_primary_10_1016_j_ccc_2012_11_007 crossref_primary_10_1016_j_yebeh_2012_07_014 crossref_primary_10_1016_j_yebeh_2021_108484 crossref_primary_10_1016_j_seizure_2021_06_011 crossref_primary_10_1016_j_yebeh_2011_03_035 crossref_primary_10_1007_s15202_013_0029_6 crossref_primary_10_1016_S1878_7762_10_70035_2 crossref_primary_10_1016_S1474_4422_15_00042_3 crossref_primary_10_1111_epi_13375 crossref_primary_10_1016_j_jneumeth_2020_108911 crossref_primary_10_1016_j_yebeh_2015_03_023 crossref_primary_10_1097_PCC_0000000000003338 crossref_primary_10_1016_j_seizure_2015_11_008 crossref_primary_10_1007_s00415_021_10925_8 crossref_primary_10_1016_j_seizure_2019_07_009 crossref_primary_10_1016_j_neuropharm_2015_11_001 crossref_primary_10_1016_j_neurot_2024_e00514 crossref_primary_10_1016_j_yebeh_2015_11_016 crossref_primary_10_1007_s15016_014_0518_7 crossref_primary_10_1097_WCO_0000000000000307 crossref_primary_10_1111_epi_13121 crossref_primary_10_1111_j_1468_1331_2009_02917_x crossref_primary_10_12968_hmed_2013_74_1_18 crossref_primary_10_3390_e24111641 crossref_primary_10_1016_j_yebeh_2022_109072 crossref_primary_10_1024_1661_8157_a002596 crossref_primary_10_1142_S0129065723500120 crossref_primary_10_1016_j_clinph_2020_09_016 crossref_primary_10_1016_j_neuroimage_2015_02_059 crossref_primary_10_1016_j_seizure_2019_10_003 crossref_primary_10_1056_NEJMe1114206 crossref_primary_10_1055_a_2051_9291 crossref_primary_10_1002_epi4_12277 crossref_primary_10_1007_s11910_015_0594_5 crossref_primary_10_1002_epi4_12388 crossref_primary_10_1007_s00134_007_0915_5 crossref_primary_10_1016_j_ebr_2020_100409 crossref_primary_10_1016_j_yebeh_2014_05_018 crossref_primary_10_2460_javma_243_7_1001 crossref_primary_10_2217_ahe_09_91 crossref_primary_10_1016_j_bspc_2016_01_002 crossref_primary_10_1016_j_cnp_2016_09_002 crossref_primary_10_1016_j_eplepsyres_2011_05_018 crossref_primary_10_1016_j_pjnns_2018_04_002 crossref_primary_10_1016_j_ncl_2011_09_005 crossref_primary_10_52965_001c_56782 crossref_primary_10_1007_s11910_013_0357_0 crossref_primary_10_1111_epi_16577 crossref_primary_10_1517_14656566_2015_997212 crossref_primary_10_3389_fphar_2018_00193 crossref_primary_10_1016_j_sleep_2014_04_021 crossref_primary_10_1142_S0129065721500246 crossref_primary_10_1007_s15202_017_1498_9 crossref_primary_10_1016_j_nrleng_2018_11_004 crossref_primary_10_1186_s12883_022_02868_y crossref_primary_10_1517_14656566_2016_1127354 crossref_primary_10_1038_s41598_022_25949_x crossref_primary_10_1007_s12028_012_9695_z crossref_primary_10_1016_j_neurol_2008_11_010 crossref_primary_10_1212_01_CON_0000284538_29811_da crossref_primary_10_4103_jmss_jmss_138_21 crossref_primary_10_1371_journal_pcbi_1008689 crossref_primary_10_1080_02688697_2017_1324618 crossref_primary_10_1007_s00115_020_01036_2 crossref_primary_10_1097_AIA_0000000000000404 crossref_primary_10_3390_ijms23158191 crossref_primary_10_1152_jn_00721_2017 crossref_primary_10_1038_s41578_018_0062_3 crossref_primary_10_7759_cureus_48173 crossref_primary_10_1186_s12883_015_0486_y crossref_primary_10_1016_j_pop_2024_02_008 crossref_primary_10_1016_j_brainres_2015_07_017 crossref_primary_10_1016_j_yebeh_2021_108312 crossref_primary_10_1016_S1634_7072_23_48698_9 crossref_primary_10_1017_S0790966700000306 crossref_primary_10_3389_fneur_2022_966480 crossref_primary_10_1109_JIOT_2021_3115505 crossref_primary_10_1111_ane_13356 crossref_primary_10_1038_s41420_023_01445_7 crossref_primary_10_1093_braincomms_fcac234 |
Cites_doi | 10.1124/jpet.103.051920 10.1212/WNL.44.8.1403 10.1093/cercor/13.8.883 10.1016/S1388-2457(00)00543-5 10.1016/S0920-1211(02)00248-6 10.1016/j.eplepsyres.2003.10.009 10.1002/ana.410290524 10.1016/j.yebeh.2003.08.025 10.1002/ana.1018 10.1212/WNL.43.11.2280 10.1152/jn.1989.61.2.417 10.1523/JNEUROSCI.20-04-01290.2000 10.1093/brain/120.6.939 10.1046/j.1528-1157.2003.55502.x 10.1097/00124509-199903000-00003 10.1212/01.WNL.0000053748.83309.28 10.1097/00124509-200109000-00013 10.1002/ana.410440609 |
ContentType | Journal Article |
Copyright | 2006 INIST-CNRS |
Copyright_xml | – notice: 2006 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 7X8 |
DOI | 10.1111/j.1528-1167.2006.00622.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef Neurosciences Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1528-1167 |
EndPage | 1503 |
ExternalDocumentID | 16981866 18185695 10_1111_j_1528_1167_2006_00622_x EPI622 |
Genre | article Journal Article Comparative Study |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29G 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAGKA AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FYBCS G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V8K V9Y VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAFWJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 7TK 7X8 |
ID | FETCH-LOGICAL-c4932-a260b3ab856180c77de1bfef5d4938552244425a696375211d4cc7966e0119a3 |
IEDL.DBID | DR2 |
ISSN | 0013-9580 |
IngestDate | Fri Jul 11 01:52:09 EDT 2025 Fri Jul 11 00:34:57 EDT 2025 Wed Feb 19 01:43:25 EST 2025 Mon Jul 21 09:16:15 EDT 2025 Tue Jul 01 03:55:51 EDT 2025 Thu Apr 24 22:53:52 EDT 2025 Wed Jan 22 16:32:36 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Status epilepticus-Seizure duration- Seizure termination-Seizure classification. 0 1 |i Nervous system diseases Epilepsy Central nervous system disease Comparative study Monitoring Cerebral disorder |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4932-a260b3ab856180c77de1bfef5d4938552244425a696375211d4cc7966e0119a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 16981866 |
PQID | 19533362 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_68863991 proquest_miscellaneous_19533362 pubmed_primary_16981866 pascalfrancis_primary_18185695 crossref_citationtrail_10_1111_j_1528_1167_2006_00622_x crossref_primary_10_1111_j_1528_1167_2006_00622_x wiley_primary_10_1111_j_1528_1167_2006_00622_x_EPI622 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2006 |
PublicationDateYYYYMMDD | 2006-09-01 |
PublicationDate_xml | – month: 09 year: 2006 text: September 2006 |
PublicationDecade | 2000 |
PublicationPlace | Malden, USA |
PublicationPlace_xml | – name: Malden, USA – name: Malden, MA – name: United States |
PublicationTitle | Epilepsia (Copenhagen) |
PublicationTitleAlternate | Epilepsia |
PublicationYear | 2006 |
Publisher | Blackwell Publishing Inc Blackwell |
Publisher_xml | – name: Blackwell Publishing Inc – name: Blackwell |
References | 1991; 29 2001; 112 1989; 61 2003; 307 1997; 120 1993; 43 1999; 15 2000; 20 2003; 13 2003; 57 1994; 44 2003; 4 1972 2001; 49 2001; 17 2003; 60 1992; 33 2003; 53 1998; 44 2003; 44 e_1_2_5_14_2 e_1_2_5_13_2 e_1_2_5_9_2 e_1_2_5_8_2 e_1_2_5_15_2 e_1_2_5_7_2 e_1_2_5_10_2 e_1_2_5_6_2 e_1_2_5_5_2 e_1_2_5_12_2 e_1_2_5_20_2 e_1_2_5_4_2 e_1_2_5_11_2 e_1_2_5_21_2 e_1_2_5_3_2 e_1_2_5_2_2 e_1_2_5_18_2 e_1_2_5_17_2 Kramer R (e_1_2_5_16_2) 1992; 33 e_1_2_5_19_2 |
References_xml | – volume: 20 start-page: 1290 year: 2000 end-page: 6 article-title: Activity‐dependent intracellular acidification correlates with the duration of seizure activity publication-title: J Neurosci – volume: 15 start-page: 5 year: 1999 end-page: 26 article-title: The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. [review][109 refs] publication-title: J ECT – volume: 57 start-page: 95 year: 2003 end-page: 109 article-title: Reduction of intracellular calcium removal rate can explain changes in seizure dynamics: studies in neuronal network models publication-title: Epilepsy Res – volume: 13 start-page: 883 year: 2003 end-page: 93 article-title: Partial cortical deafferentation promotes development of paroxysmal activity publication-title: Cereb Cortex – volume: 43 start-page: 2280 year: 1993 end-page: 4 article-title: Carbamazepine withdrawal: effects of taper rate on seizure frequency publication-title: Neurology – volume: 61 start-page: 417 year: 1989 end-page: 26 article-title: Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition publication-title: J Neurophysiol – volume: 307 start-page: 129 year: 2003 end-page: 37 article-title: The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy publication-title: J Pharmacol Exp Therap – volume: 4 start-page: 740 year: 2003 end-page: 5 article-title: A retrospective analysis of the effects of magnet‐activated stimulation in conjunction with vagus nerve stimulation therapy publication-title: Epilepsy Behav – start-page: 25 year: 1972 end-page: 90 – volume: 49 start-page: 659 year: 2001 end-page: 64 article-title: How long do new‐onset seizures in children last? publication-title: Ann Neurol – volume: 53 start-page: 65 year: 2003 end-page: 80 article-title: External excitatory stimuli can terminate bursting in neural network models publication-title: Epilepsy Res – volume: 29 start-page: 575 year: 1991 article-title: Adenosine and seizure termination.[comment] publication-title: Ann Neurol – volume: 44 start-page: 908 year: 1998 end-page: 12 article-title: Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus publication-title: Ann Neurol – volume: 60 start-page: 975 year: 2003 end-page: 8 article-title: Occurrence of seizure clusters and status epilepticus during inpatient video‐EEG monitoring publication-title: Neurology – volume: 17 start-page: 210 year: 2001 end-page: 15 article-title: ECT in the treatment of status epilepticus publication-title: J ECT – volume: 44 start-page: 752 year: 2003 end-page: 60 article-title: Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo publication-title: Epilepsia – volume: 44 start-page: 1403 year: 1994 end-page: 7 article-title: The secondarily generalized tonic‐clonic seizure: a videotape analysis. [see comment] publication-title: Neurology – volume: 120 start-page: 939 year: 1997 end-page: 53 article-title: Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. [review][38 refs] publication-title: Brain – volume: 112 start-page: 241 year: 2001 end-page: 9 article-title: Epileptic seizures are characterized by changing signal complexity publication-title: Clin Neurophysiol – volume: 33 issue: suppl 3 year: 1992 article-title: The duration of secondarily generalized tonic‐clonic seizures publication-title: Epilepsia – volume: 33 issue: 3 year: 1992 ident: e_1_2_5_16_2 article-title: The duration of secondarily generalized tonic‐clonic seizures publication-title: Epilepsia – ident: e_1_2_5_7_2 doi: 10.1124/jpet.103.051920 – ident: e_1_2_5_15_2 doi: 10.1212/WNL.44.8.1403 – ident: e_1_2_5_3_2 doi: 10.1093/cercor/13.8.883 – ident: e_1_2_5_2_2 doi: 10.1016/S1388-2457(00)00543-5 – ident: e_1_2_5_11_2 doi: 10.1016/S0920-1211(02)00248-6 – ident: e_1_2_5_8_2 doi: 10.1016/j.eplepsyres.2003.10.009 – ident: e_1_2_5_5_2 doi: 10.1002/ana.410290524 – ident: e_1_2_5_13_2 doi: 10.1016/j.yebeh.2003.08.025 – ident: e_1_2_5_18_2 doi: 10.1002/ana.1018 – ident: e_1_2_5_20_2 doi: 10.1212/WNL.43.11.2280 – ident: e_1_2_5_4_2 doi: 10.1152/jn.1989.61.2.417 – ident: e_1_2_5_6_2 doi: 10.1523/JNEUROSCI.20-04-01290.2000 – ident: e_1_2_5_17_2 – ident: e_1_2_5_14_2 doi: 10.1093/brain/120.6.939 – ident: e_1_2_5_9_2 doi: 10.1046/j.1528-1157.2003.55502.x – ident: e_1_2_5_10_2 doi: 10.1097/00124509-199903000-00003 – ident: e_1_2_5_19_2 doi: 10.1212/01.WNL.0000053748.83309.28 – ident: e_1_2_5_12_2 doi: 10.1097/00124509-200109000-00013 – ident: e_1_2_5_21_2 doi: 10.1002/ana.410440609 |
SSID | ssj0007673 |
Score | 2.287187 |
Snippet | Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could... Purpose: More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could... More information is needed regarding how long seizures typically last, since this influences treatment decisions. Seizure type and other factors could... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1499 |
SubjectTerms | Adult Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Cerebral Cortex - physiopathology Electroencephalography - methods Electroencephalography - statistics & numerical data Epilepsy - classification Epilepsy - diagnosis Epilepsy - physiopathology Functional Laterality - physiology Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Investigative techniques, diagnostic techniques (general aspects) Medical sciences Monitoring, Physiologic - methods Monitoring, Physiologic - statistics & numerical data Nervous system Nervous system (semeiology, syndromes) Neurology Neuropharmacology Pharmacology. Drug treatments Radionuclide investigations Sampling Studies Seizure classification Seizure duration Seizure termination Status epilepticus Status Epilepticus - diagnosis Status Epilepticus - physiopathology Terminology as Topic Time Factors Videotape Recording |
Title | How Long Do Most Seizures Last? A Systematic Comparison of Seizures Recorded in the Epilepsy Monitoring Unit |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1528-1167.2006.00622.x https://www.ncbi.nlm.nih.gov/pubmed/16981866 https://www.proquest.com/docview/19533362 https://www.proquest.com/docview/68863991 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5CDiVQ0kfS1H1sdcjVS2zZsnUqIdmwabMh5AG5GcmSy5JgL7WXtvn1nbG8u3VJIITcDHogyTPSN5rRNwC7hZShFqhplp7nRkLkvgwT43Odp9wahCCaHjhPTsX4Kvp2HV938U_0FsbxQywv3Egz2v2aFFzpuq_kcYgWUCCShU9BhOGQ8GTABdHoH56vmKQS0TmbA-7LON3rB_Xc21HvpHo5UzUuWuGyXdwHR_votj2ejl7BzWJiLirlZjhv9DC_-4_z8Xlm_ho2OxTL9p3YvYE1W76FF5POT78Ft-PqFzupyh_ssGKTqm7YhZ3ezdG0Zyeqbr6yfXaxpJBmB8tciKwqVjWdZWwNm5YMYSobzXC0s_oPc_sQXUgygszbcHk0ujwY-11eBz-PEC76Cm0ozZVOEbule3mSGBvowhaxweI0RkQYRbiVKIGbQ4LwIjBRnidol1kiqFP8HayXVWnfA-OWSjiCoAKhhtFaGml5WihtiBhNepAsfmGWd5znlHrjNvvH9sG1zGgtKSMnxfjhWma_PQiWLWeO9-MRbQY9KVk1JFQkZOzBl4XYZKjF5JpRpa3mdUbOTI5Y4uEaIk0JTAYe7Dh5W_UuZEtb6EHcSs2jx5uNzo7x48MT232EDXcfRQF3n2C9-Tm3nxGhNXqAunf8fdBq4F-9wCp0 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3fS9xAEMeHotAWRPvTRlvdh77mMNlkk30S0ZNT76TUK_gWstlNEY_kMDmq_vXOZHN3jShI6Vsg2ZBsZjaf2dn9DsD3XEpfCfQ0Q9tzAyEyV_qRdrnKYm40IoiiDc6jczH4FZxehpdtOSDaC2P1IRYTbuQZzXhNDk4T0l0vD30MgTwRzZMKwvd7CJSrTbqOCOnnUksqEm262eOuDOO97rKeJ-_U-VetTdMKuy239S6eAtIu3zY_qOMNmMxfza5Lue7NatXL7h-pPv6nd38H6y3IsgNree_hlSk-wOtRm6r_CJNB-YcNy-I3OyrZqKxqdmGu7mcY3bNhWtX77IBdLFSk2eGiHCIr8-WVNjg2ml0VDEmV9af4uNPqjtmhiOYkGVHzJxgf98eHA7ct7eBmARKjm2IYpXiqYsS3eC-LIm08lZs81Hg6DhEKgwBHk1Tg-BAhYXg6yLIIQzNDGnUp_wwrRVmYL8C4oTMcOShH2tBKSS0Nj_NUadJGkw5E82-YZK3sOVXfmCR_hT_Ylwn1JRXlpGV-2JfJrQPeouXUSn-8oM1Ox0yWDQmMhAwd2J3bTYKOTNmZtDDlrEoon8kRJ56_QsQx8aTnwKY1uOXdhWyUCx0IG7N58fMm_R8neLD1j-124c1gPBomw5Pzs214a6enaP3dV1ipb2bmGwJbrXYaR3wAarktmQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS9xAEB-KBSlIP6y2qVb3oa85TDbZZJ-KeHec9U6kKvgWstmNiJKEJofWv74z2dxdUyxI6VtgP5LdzOz-Zmf2NwBfcil9JVDTDF3PDYTIXOlH2uUqi7nRCEEUXXCenYrJZfDtKrzq4p_oLozlh1geuJFmtOs1KXil876Shz5aQJ6IFj4F4fsDxJMvA3w5hXcNv6-opCLReZs97sowPuhH9TzZU2-r2qjSGmctt-kunsKjfXjb7k_jN3C7GJkNS7kdzBs1yB7_IH38P0N_C687GMsOrdy9gxem2IT1Weeofw93k_KeTcvimg1LNivrhp2bm8c52vZsmtbNV3bIzpcc0uxomQyRlfmqpjWNjWY3BUOcykYVfm1V_2R2IaITSUaYeQsuxqOLo4nbJXZwswDxopuiEaV4qmIEb_FBFkXaeCo3eaixOA4REgYBriWpwNUhQnzh6SDLIjTMDDHUpXwb1oqyMB-BcUMlHFFQjlhDKyW1NDzOU6WJGU06EC1-YZJ1pOeUe-Mu-c34wblMaC4pJScF-eFcJg8OeMuWlSX-eEabvZ6UrBoSLBIydGB_ITYJqjH5ZtLClPM6IW8mRzDx9xoijglNeg58sPK26l3IlrfQgbCVmmd_bzI6O8aHT__Ybh_Wz4bjZHp8erIDr-zZFAXf7cJa82NuPiNaa9Req4a_AKThLEg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=How+Long+Do+Most+Seizures+Last%3F+A+Systematic+Comparison+of+Seizures+Recorded+in+the+Epilepsy+Monitoring+Unit&rft.jtitle=Epilepsia+%28Copenhagen%29&rft.au=Jenssen%2C+Sigmund&rft.au=Gracely%2C+Edward+J.&rft.au=Sperling%2C+Michael+R.&rft.date=2006-09-01&rft.issn=0013-9580&rft.eissn=1528-1167&rft.volume=47&rft.issue=9&rft.spage=1499&rft.epage=1503&rft_id=info:doi/10.1111%2Fj.1528-1167.2006.00622.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1528_1167_2006_00622_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0013-9580&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0013-9580&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0013-9580&client=summon |